Betterlife Pharma Inc. Files for Patent Protection of New Formulation Used In the Treatment of Depression and Mood Disorders
BetterLife Pharma Inc., an emerging biotechnology company based in Canada, applied for patent protection of new 2-Bromo-LSD formulations and their use in the treatment of depression and mood disorders. Depression and mood disorders affect millions of men and women every year, but most are not aware of it. Women tend to be more psychologically vulnerable to mood disorders than men.
Read The Full Blog- https://www.coherentmarketinsights.com/news/betterlife-pharma-inc-files-for-patent-protection-of-new-formulation-used-in-the-treatment-of-depression-and-mood-disorders-248
Write a comment